ShardaCare-Healthcity announced the inauguration of a bone marrow transplant (BMT) centre in Greater Noida. The facility was inaugurated by Brajesh Pathak, Deputy Chief Minister and Minister of Health & Family Welfare, Uttar Pradesh, in the presence of medical professionals and representatives from the Sharda Group.
The BMT centre is designed to provide treatment for haematological conditions including leukaemia, lymphoma, thalassaemia and aplastic anaemia. It includes infrastructure, infection-controlled units and a multidisciplinary team for transplant care.
The centre will offer bone marrow transplant procedures for paediatric and adult patients, including matched sibling, matched unrelated donor and haploidentical transplants. It will also provide autologous transplants for autoimmune conditions such as multiple sclerosis, supported by therapies including high-dose treatment, immunotherapy and graft manipulation. The facility includes HEPA-filtered transplant units, diagnostics and immunology support for donor matching and patient monitoring. Services include autologous, allogeneic and haploidentical transplants with integrated oncology, haematology and critical care.
P.K. Gupta, Chairman, Sharda Group, said: “With the launch of North India’s largest Bone Marrow Transplant Centre, we are taking a decisive step towards building a future-ready healthcare ecosystem. This facility reflects our commitment to making highly specialized, life-saving treatments like BMT accessible at scale, while setting new benchmarks in clinical excellence and patient care.”
Y.K. Gupta, Vice Chairman, Sharda Group, said: “The establishment of this advanced BMT Centre strengthens ShardaCare Healthcity’s position as a leader in tertiary care. By combining cutting-edge technology with expert medical teams, we aim to deliver superior transplant outcomes and bring world-class hematology care closer to patients across North India.”
Dr Pawan Kumar Singh, Vice Chairman, Department of Haemato-Oncology & BMT, ShardaCare-Healthcity, said: “Bone Marrow Transplant is a life-saving and often curative treatment for several serious blood disorders. At ShardaCare–Healthcity, we are not only advancing BMT services with precision, safety, and improved outcomes, but also actively supporting the Government of India’s mission to eliminate sickle cell disease by 2047 through comprehensive and curative care. Our focus is to expand access, enhance outcomes, and bring hope to patients and families.”
The facility provides transplant care within a single system aimed at improving access to treatment in the region.